Positive Feedback Loops in Alzheimer's Disease: The Alzheimer's Feedback Hypothesis

被引:38
作者
Doig, Andrew J. [1 ]
机构
[1] Univ Manchester, Sch Biol Sci, Fac Biol Med & Hlth, Div Neurosci & Expt Psychol, Oxford Rd, Manchester M13 9PT, Lancs, England
基金
英国生物技术与生命科学研究理事会;
关键词
Aggregation; amyloid; amyloid-beta protein precursor; directed acyclic graph; drug discovery; peptide; systems biology; AMYLOID-BETA-PEPTIDE; MILD COGNITIVE IMPAIRMENT; SIMPLEX-VIRUS TYPE-1; A-BETA; OXIDATIVE STRESS; ANTIINFLAMMATORY DRUGS; LIPID-PEROXIDATION; PRECURSOR PROTEIN; BRAIN; OXYSTEROLS;
D O I
10.3233/JAD-180583
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The dominant model for Alzheimer's disease (AD) is the amyloid cascade hypothesis, in which the accumulation of excess amyloid-beta (A beta) leads to inflammation, excess glutamate and intracellular calcium, oxidative stress, tau hyperphosphorylation and tangle formation, neuronal loss, and ultimately dementia. In a cascade, AD proceeds in a unidirectional fashion, with events only affecting downstream processes. Compelling evidence now exists for the presence of positive feedback loops in AD, however, involving oxidative stress, inflammation, glutamate, calcium, and tau. The pathological state of AD is thus a system of positive feedback loops, leading to amplification of the initial perturbation, rather than a linear cascade. Drugs may therefore be effective by targeting numerous points within the loops, rather than concentrating on upstream processes. Anti-inflammatories and anti-oxidants may be especially valuable, since these processes are involved in many loops and hence would affect numerous processes in AD.
引用
收藏
页码:25 / 36
页数:12
相关论文
共 120 条
[1]   β-amyloid peptides induce mitochondrial dysfunction and oxidative stress in astrocytes and death of neurons through activation of NADPH oxidase [J].
Abramov, AY ;
Canevari, L ;
Duchen, MR .
JOURNAL OF NEUROSCIENCE, 2004, 24 (02) :565-575
[2]   A central role for dityrosine crosslinking of Amyloid-β in Alzheimer's disease [J].
Al-Hilaly, Youssra K. ;
Williams, Thomas L. ;
Stewart-Parker, Maris ;
Ford, Lenzie ;
Skaria, Eldhose ;
Cole, Michael ;
Bucher, William Grant ;
Morris, Kyle L. ;
Sada, Alaa Abdul ;
Thorpe, Julian R. ;
Serpell, Louise C. .
ACTA NEUROPATHOLOGICA COMMUNICATIONS, 2013, 1
[3]   Regulation of APC/C-Cdh1 and Its Function in Neuronal Survival [J].
Almeida, Angeles .
MOLECULAR NEUROBIOLOGY, 2012, 46 (03) :547-554
[4]   Calcium Hypothesis of Alzheimer's disease and brain aging: A framework for integrating new evidence into a comprehensive theory of pathogenesis [J].
Arancio, Ottavio ;
Bezprozvanny, Ilya ;
Berger, Theodore ;
Bouteiller, Jean-Marie ;
Carrillo, Maria ;
Disterhoft, John ;
Foskett, Kevin ;
Khachaturian, Ara S. ;
LaFerla, Frank ;
Landfield, Philip W. ;
Masliah, Eliezer ;
Mattson, Mark ;
Michaelis, Mary L. ;
Nixon, Ralph ;
Snyder, Heather ;
Stutzmann, Grace ;
Thibault, Olivier ;
Yang, Austin ;
Khachaturian, Zaven S. ;
Scholz, Ken .
ALZHEIMERS & DEMENTIA, 2017, 13 (02) :178-182
[5]   The overlap between vascular disease and Alzheimer's disease - lessons from pathology [J].
Attems, Johannes ;
Jellinger, Kurt A. .
BMC MEDICINE, 2014, 12
[6]   Viscoelastic and ultrastructural characteristics of whole blood and plasma in Alzheimer-type dementia, and the possible role of bacterial lipopolysaccharides (LPS) [J].
Bester, Janette ;
Soma, Prashilla ;
Kell, Douglas B. ;
Pretorius, Etheresia .
ONCOTARGET, 2015, 6 (34) :35284-35303
[7]   Neuronal calcium mishandling and the pathogenesis of Alzheimer's disease [J].
Bezprozvanny, Ilya ;
Mattson, Mark P. .
TRENDS IN NEUROSCIENCES, 2008, 31 (09) :454-463
[8]   Oxysterols and Alzheimer's disease [J].
Bjorkhem, I. ;
Heverin, M. ;
Leoni, V. ;
Meaney, S. ;
Diczfalusy, U. .
ACTA NEUROLOGICA SCANDINAVICA, 2006, 114 :43-49
[9]   Crossing the barrier:: oxysterols as cholesterol transporters and metabolic modulators in the brain [J].
Bjorkhem, I. .
JOURNAL OF INTERNAL MEDICINE, 2006, 260 (06) :493-508
[10]   Amyloid-β and Tau The Trigger and Bullet in Alzheimer Disease Pathogenesis [J].
Bloom, George S. .
JAMA NEUROLOGY, 2014, 71 (04) :505-508